West Nile fever: Lessons from the 2002 season

Steven M. Gordon, MD
Department of Infectious Disease, The Cleveland Clinic

Carlos M. Isada, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Steven M. Gordon, MD, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: gordons@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Steven M. Gordon, MD
Department of Infectious Disease, The Cleveland Clinic

Carlos M. Isada, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Steven M. Gordon, MD, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: gordons@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Steven M. Gordon, MD
Department of Infectious Disease, The Cleveland Clinic

Carlos M. Isada, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Steven M. Gordon, MD, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: gordons@ccf.org

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.